Search Results 1361-1370 of 18171 for Cervical%2BCancer
2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma. XmAb18968 (CD3-CD38) in ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as docetaxel ...
Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. ... cervical cancer, or other cancer from which the subject has been ...
Dr. E. Aubrey Thompson leads research in the Hormones & Cancer Lab at Mayo Clinic to develop integrated models of the genomic architecture of breast cancer.
The purpose of this study is to evaluate olaparib and temozolomide in treating patients with uterine leiomyosarcoma (LMS) that has spread to other places of the ...
Patients with HPV(+)OPSCC complete aggressive de‐escalation of adjuvant therapy without increasing risk of cancer progression ... "Evidence quickly arose that ...
Supported research includes: Clinical pharmacokinetic studies conducted within phase 1 and phase 2 clinical trials funded by the National Cancer Institute (NCI) ...
A Prospective Study to Evaluate the Role of Tumor Sequencing in Women Receiving Palbociclib for Advanced Hormone Receptor (HR)-Positive Breast Cancer (PROMISE; ...
Gene expression profiling tests analyze a number of different genes within your cancer cells to predict your risk of cancer recurrence. The results help ...
The major purpose of this study is to evaluate a laboratory developed test that measures multiple breast cancer-specific biomarker proteins and multiple ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation can make a difference in the future of healthcare. Give now to support Mayo Clinic's research.